Dose-effect relationships between manganese exposure and neurological, neuropsychological and pulmonary function in confined space bridge welders by Bowler, Rosemarie M. et al.
ORIGINAL ARTICLE
Dose–effect relationships between manganese exposure and
neurological, neuropsychological and pulmonary function
in confined space bridge welders
Rosemarie M Bowler, Harry A Roels, Sanae Nakagawa, Marija Drezgic, Emily Diamond, Robert
Park, William Koller, Russell P Bowler, Donna Mergler, Maryse Bouchard, Donald Smith, Roberto
Gwiazda, Richard L Doty
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
See end of article for
authors’ affiliations
. . . . . . . . . . . . . . . . . . . . . . . .
Correspondence to:
Dr R M Bowler, San
Francisco State University,







. . . . . . . . . . . . . . . . . . . . . . . .
Occup Environ Med 2007;64:167–177. doi: 10.1136/oem.2006.028761
Background: Although adverse neuropsychological and neurological health effects are well known among
workers with high manganese (Mn) exposures in mining, ore-processing and ferroalloy production, the risks
among welders with lower exposures are less well understood.
Methods: Confined space welding in construction of a new span of the San Francisco–Oakland Bay Bridge
without adequate protection was studied using a multidisciplinary method to identify the dose–effect
relationship between adverse health effects and Mn in air or whole blood. Bridge welders (n = 43) with little or
no personal protection equipment and exposed to a welding fume containing Mn, were administered
neurological, neuropsychological, neurophysiological and pulmonary tests. Outcome variables were
analysed in relation to whole blood Mn (MnB) and a Cumulative Exposure Index (CEI) based on Mn-air,
duration and type of welding. Welders performed a mean of 16.5 months of welding on the bridge, were on
average 43.8 years of age and had on average 12.6 years of education.
Results: The mean time weighted average of Mn-air ranged from 0.11–0.46 mg/m3 (55% .0.20 mg/m3).
MnB .10 mg/l was found in 43% of the workers, but the concentrations of Mn in urine, lead in blood and
copper and iron in plasma were normal. Forced expiratory volume at 1s: forced vital capacity ratios (FEV1/
FVC) were found to be abnormal in 33.3% of the welders after about 1.5 years of welding at the bridge.
Mean scores of bradykinesia and Unified Parkinson Disease Rating Scale exceeded 4 and 6, respectively.
Computer assisted tremor analysis system hand tremor and body sway tests, and University of Pennsylvania
Smell Identification Test showed impairment in 38.5/61.5, 51.4 and 88% of the welders, respectively.
Significant inverse dose–effect relationships with CEI and/or MnB were found for IQ (p(0.05), executive
function (p(0.03), sustaining concentration and sequencing (p(0.04), verbal learning (p(0.01), working
(p(0.04) and immediate memory (p(0.02), even when adjusted for demographics and years of welding
before Bay Bridge. Symptoms reported by the welders while working were: tremors (41.9%); numbness
(60.5%); excessive fatigue (65.1%); sleep disturbance (79.1%); sexual dysfunction (58.1%); toxic
hallucinations (18.6%); depression (53.5%); and anxiety (39.5%). Dose–effect associations between CEI
and sexual function (p,0.05), fatigue (p,0.05), depression (p,0.01) and headache (p,0.05) were
statistically significant.
Conclusions: Confined space welding was shown to be associated with neurological, neuropsychological and
pulmonary adverse health effects. A careful enquiry of occupational histories is recommended for all welders
presenting with neurological or pulmonary complaints, and a more stringent prevention strategy should be
considered for Mn exposure due to inhalation of welding fume.
M
anganese (Mn) exposure through welding fume has
been reported to cause parkinsonian syndrome, some-
times described as welding fume-related parkinsonism
and often misdiagnosed as Parkinson’s disease because of
similarities in neurological features including tremor, masked
facies and generalised bradykinesia.1 However, important
differences in movement disturbance between Mn-induced
parkinsonism (also called manganism) and idiopathic
Parkinson’s disease (IPD) include an awkward high-stepping
dystonic gait in manganism, which is in stark contrast with the
typical shuffling gait in patients with IPD, and the tendency to
lose balance by falling backward in IPD and forward in
manganism. Additionally, tremor characteristics are different,
usually resting tremor in IPD and postural intention tremor in
manganism.1 Magnetic resonance imaging (MRI) may be used
to differentiate IPD from Mn-induced parkinsonism if a patient
has had excess Mn exposure within the previous 6 months.2
Positive MRIs can show cerebral Mn2+ deposition in both
animals and humans, especially in the globus pallidus (possibly
in the striatum), by exhibiting a T1-weighted signal hyper-
intensity.3 IPD, however, is associated with lesions in the
substantia nigra pars compacta, and does not exhibit MRI
abnormality in the globus pallidus. Two other key features
differentiating between Mn-induced parkinsonism and IPD are:
Abbreviations: Cal-OSHA, California Division of Occupational Safety
and Health; CATSYS, computer assisted tremor analysis system; CEI,
Cumulative Exposure Index; FCAW, Flux Cored Arc Welding; FVC, forced
vital capacity; FEV1, forced expiratory volume at 1 s; IPD, idiopathic
Parkinson’s disease; Mn-air, manganese air levels; MnB, whole blood
manganese; MRI, magnetic resonance imaging; SCL-90-R, Symptom
Checklist 90-Revised; SMAW, Shielded Metal Arc Welding; UPDRS,
Unified Parkinson Disease Rating Scale; UPSIT, University of Pennsylvania
Smell Identification Test; WAIS-III, Wechsler Adult Intelligence Scale; WMS
III, Wechsler Memory Scale
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(1) a younger age of onset for Mn-exposed workers and (2)
little or no response to L-dopa among Mn-induced parkinson-
ism cases.4 5 Case reports of neurological findings in career
welders exposed to Mn have shown dystonia bilaterally in the
shoulders and four distal limbs, as well as other parkinsonian
features—for example, tremor and postural instability.5 6
Welders have been reported to be exposed to ‘‘a wide variety
of potential respiratory hazards’’,7 8 although earlier studies did
not show increases in chronic bronchitis.9 However, shipyard
welders have been reported to have a higher standardised
mortality ratio for lung cancer, a finding which was also
supported by the California Occupational Mortality Survey,
after adjustment for smoking and asbestos exposure. Sjögren
presented evidence of a causal relationship between exposure to
stainless steel welding and lung cancer.10
Diagnosis of Mn intoxication in workers actively exposed to
excessive Mn in welding fumes can be further supported by
biomarkers of exposure indicating increased internal Mn
concentrations—for example, in whole blood and to a lesser
extent in plasma/serum or urine. Sjögren et al11 reported a mean
concentration of 8.4 mg/l for whole blood Mn (MnB) in welders,
whereas in other industrial settings the mean MnB ranged from
8.1 to 25.3 mg/l. No clear cutoff value of MnB is currently agreed
upon, but HAR postulates that any values .10 mg/l is of
concern.
Mn air levels (Mn-air) as reported in a few welder studies
indicate that aerosols in welding operations (external exposure)
usually contain ,0.5 mg Mn/m3 (total dust), but sometimes
they are .1 mg Mn/m3. A paramount feature of welding fume
is that most of the airborne particles are in the respirable
fraction (particle size ,10 mm).12 It is astonishing that reliable
levels of respirable Mn particulate have rarely been reported,
given the importance of the pulmonary uptake of Mn via the
alveoli and its significance for Mn distribution to and effects on
the central nervous system.13 It should be pointed out that
inhalation exposure to Mn is for most of the jurisdictions
regulated on the basis of total (or inhalable) dust: however, in
the particular case of welding, a permissible exposure level
established on the respirable fraction would enhance health
prevention strategies.
Neuropsychological testing methods used over the past two
decades have successfully differentiated Mn-exposed welders
from unexposed controls.4 6 11 There have been 13 reports on
welders showing deficits for motor, tremor, memory and
neurocognitive domains, as well as for sleep, sexual function
and vision. Although not all reports dealt with all of these
domains, 11 studies indicated slowing of motor speed/
efficiency4 6 11 14–21 and tremor3 4 6 14–17 19–22; eight found loss of
neurocognitive functioning4 6 11 14 16 18 19 21; and six reported
diminished memory function.4 6 11 14 18 21 Six studies reported
sleep disturbances4 6 11 14 15 17 and three sexual problems.4 6 14
Vision was assessed in only two studies, and both found loss of
colour vision associated with Mn exposure.6 14
Welders exposed to Mn-containing welding fumes and dust
have rarely been investigated by clinical neuropsychologists
using an epidemiological study design in which actual
measurements of internal and external exposure to Mn are
studied in relation to outcome variables of a comprehensive test
battery (including measures of IQ). Therefore, in the latter part
of 2004, we decided to evaluate a welder group with health
complaints, identified as employees on the reconstruction
project of the San Francisco–Oakland Bay Bridge, which was
damaged during the 1989 earthquake. The work on a
vulnerable portion of the East span of the bridge began in
2003, requiring confined space welding of 28 anchoring
foundations or piers, consisting of steel piles and footing boxes.
The welding operations took place below the Bay’s surface in
unpressurised cofferdams. During the first 1.5 years of welding
on the support piers for the new bridge, welders began to
express concerns of ill health feared to be the result of exposure
to fumes due to confined space welding. During this period the
welders were not required to wear personal protective equip-
ment, and ventilation was minimal or ineffective. After
receiving health complaints from almost 90% of the welders
employed on the project, workers’ compensation evaluations
were enacted, which supported their report of adverse health
effects. A multidisciplinary study group took advantage of this
‘‘natural experiment’’ for undertaking additional clinical
evaluations (1) to assess the extent of neurological, neuropsy-
chological, neurophysiological and pulmonary effects, (2) to
explore whether these effects were associated with internal
and/or external measures of Mn exposure and (3) to define a
tentative permissible exposure level for Mn in welding fume.
METHODS
Study population
The study group consisted of 49 welders (45 men and
4 women), who were engaged in manual Shielded Metal Arc
Welding (SMAW) and automated Flux Cored Arc Welding
(FCAW) in confined small spaces during the construction of the
new Bay Bridge. The four women, too few to analyse as a group,
and two male individuals whose scores on a test of memory
malingering23 indicated low effort were evaluated, but excluded
from the statistical analysis. All the welders underwent physical
examinations before their employment on the bridge and were
found to be healthy. The final group of 43 male welders
remained for analysis in the current study.
Almost 90% of the welders employed over several months on
this project during 2003–4 (based on the employer’s confined
space entry logs)24 were evaluated for workers’ compensation.
To determine whether their health complaints could be
medically documented, a comprehensive neuropsychological
evaluation was conducted. As part of this evaluation, detailed
health, lifestyle, work and exposure histories were obtained
during individual clinical interviews and during testing. All
workers stated that they had previously been in good health
and that this was their first experience of confined space
welding. None of the welders reported excessive alcohol
consumption, which was generally low overall.
Procedures
The participants signed informed consent forms approved by
the San Francisco State University’s Institutional Review Board,
and thereby agreed to use their clinical data from their workers’
compensation evaluations, which included Health Insurance
Portability and Accountability Act consents.
All tests were double scored using the methods detailed in
their respective manuals by specialists of each of the disciplines
(neuropsychology, neurology, neurophysiology and pulmonol-
ogy). Data were then double entered in the SPSS V.13
programme to assure accuracy.
Study design
For the clinical workers’ compensation evaluations, RMB, in
her role as principal neuropsychologist, conducted clinical
history interviews and administered tests of motivation. Five
neuropsychologists administered a neuropsychological test
battery, which included IQ testing, tests of executive, motor
and other cognitive functions; sensory testing including vision
and smell; and scales of symptoms, affect and mood.
In January 2005, the welders were also invited for a
multidisciplinary investigation, during which they were sub-
jected to neurological examinations and tests for lung function
and olfaction. A board certified neurologist (WK) performed
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neurological examinations and a PhD candidate (MB), trained
in neurotoxicology, administered hand tremor and body sway
tests. Two certified pulmonary technicians assessed lung
function with spirometry. Psychometrician graduate students
in psychology administered smell tests, scales of autonomic
nervous system function, and a self-report evaluation of sleep
and sexual function. Blood and urine samples were collected by
a certified phlebotomist for trace metal analysis. Additional
information on exposure histories were recorded by an
experienced industrial toxicologist (HAR).
Exposure assessment
Air measurements
Reports of employer-commissioned air sampling at various
locations on the bridge project, for California Division of
Occupational Safety and Health (Cal-OSHA) compliance
purposes, were made available by the Cal-OSHA inspectors.
However, the actual sampling in the field was done by
independent non-employer-affiliated laboratories, and all
analyses were carried out autonomously, independent from
employer control.
The results of the analyses for Mn and other metals in the
confined space air samples taken at the Bay Bridge during
January 2003 to June 2004 were averaged over three time
periods (January to June 2003, July to December 2003 and
January to June 2004) by type of welding: automated weld-
ing (FCAW) and manual stick welding (SMAW). For the
period July to December 2004, for which no personal air
sampling data were available, levels from the preceding 6-
month period were used. A Cumulative Mn Exposure Index
(CEI) was calculated for each welder (fig 1) using the self-
reported percentage of time a welder performed FCAW or
SMAW during his or her employment in the successive 6-
month periods. Percentage of time was multiplied by estimated
average levels of Mn-air for the two welding types, multiplied
by the number of months worked, and then summed over the
four time periods.
Biomarkers
Samples of 4 and 2 ml blood were collected by venipuncture
using a 19-gauge butterfly catheter and heparinised tubes
(BD#367 734). The 2-ml sample was then centrifuged at 800 g
for 10 min at room temperature (about 25 C̊) to separate the
plasma. A spot-urine sample (50–200 ml) was collected, from
which a 1-ml aliquot was taken for creatinine analysis. Whole
blood, plasma and urine were analysed in the trace metal
facility at the University of California Santa Cruz (DS). The
concentrations of Mn in whole blood, plasma and urine, and
the plasma concentrations of copper and iron were determined
by high-resolution inductively coupled plasma/mass spectro-
metry25; Zeeman graphite furnace atomic absorption spectro-
scopy was used for lead in whole blood.
Neurological and neuropsychological evaluation
Neurological assessment
For the clinical neurological examination, the neurologist used
the motor and the activities of daily living scales of the Unified
Parkinson Disease Rating Scale (UPDRS).26 The UPDRS is the
most widely used instrument for measuring severity of
parkinsonian symptoms qualitatively and quantitatively in
clinical research and practice. It has high validity, and high
inter-rater and intra-rater reliability. Computer assisted tremor
analysis system (CATSYS)-2000 (Danish Product Development)
was used to determine postural hand tremor intensity and
bodily sway according to standardised procedures.27
Neuropsychological testing
The comprehensive neuropsychological examination included
the following tests: for IQ, the Wechsler Adult Intelligence
Scale (WAIS-III) and Wechsler Memory Scale (WMS III)28; for
executive function, Rey–Osterrieth Complex Figure,29 Stroop
Colour Word30 and Trail Making Tests A and B29; for verbal
function, animal naming, Controlled Oral Word Association
Test,29 Wide Range Achievement Test 3 reading subtest29 and
the Boston Naming Test29; for motor function, Fingertapping,
Dynamometer, Grooved Pegboard and Santa Ana Pegboard
Test29; for neuropsychiatric symptomatology, the Beck
Figure 1 Construction of the Cumulative Exposure Index (CEI) based on type of welding, air measurements and months worked.
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Depression Inventories-II and Beck Anxiety Inventories,29 the
Symptom Checklist 90-Revised (SCL-90-R),31 and Satisfaction
with Life Scale and Quality of Life Scale 32; and for malingering,
Test of Memory Malingering23 and the Rey 15-item test.29
Spirometry, olfaction and vision tests
The spirometry test results were evaluated by a board-certified
pulmonologist (RPB). Data analysed are forced expiratory
volume at 1 s (FEV1), forced vital capacity (FVC) and the
FEV1:FVC ratio. In total, spirometry testing reports were
available for three points in time: after working on the bridge
for an average of 1.5 months (time 1), after 10.8 months (time
2) and after an average of 20.9 months (time 3) of work on the
bridge (study date in January 2005).
For olfactory function testing, we used the University of
Pennsylvania Smell Identification Test (UPSIT), which consists
of 40 ‘‘scratch and sniff’’ odorants administered according to
standardised instructions.33 The scores are summed and
interpreted using the UPSIT norms to determine normosmia,
microsmia and anosmia.
For the visual function, the Snellen Visual Acuity Test, the
Lanthony 15-hue Test for colour vision and the Vistech Contrast
Sensitivity Test were used.34
Missing data
Analyses computing the IQ scores could not be done for eight
participants who did not complete all of the subtests of the
WAIS or WMS necessary to compute the summary IQs. These
participants were given alternate IQ measures in Spanish.
Impairment definition
The neuropsychological tests were scored according to the test
publishers’ norms, which are adjusted for age and/or education.
Scores of 1 standard deviation (SD; for whites) and 1.25 SD (for
non-whites) below the mean of the reported test norms were
categorised as impaired.6 The normative data used to compute
the impairment level for the tremor are from Després et al.27
Spirometry was evaluated according to the American Thoracic
Society Standards and Guidelines35 for mean predicted values to
indicate different levels of lung function (mild, moderate and
severe).36 A cut-off of ,75 was used to determine abnormality
for FEV1:FVC (%). For the UPSIT, clinical olfactory diagnoses
were given according to age-adjusted and sex-adjusted centile
norms from the manual.33 Diagnoses of at least mild microsmia
or anosmia were classified as impaired. For the SCL-90-R,
T scores, mean (SD) 50 (10), based on sex-adjusted adult
norms, were used to derive impairment ratings.
Statistical analyses
Demographic characteristics, biological and exposure results
were analysed using descriptive statistics, and for trace metals
in whole blood, plasma or urine high normal cut-off values or
normal ranges are shown (table 1). Table 2 shows the
neuropsychological mean test scores, SDs and prevalence
percentage of impairment using the normative data.
Multiple regression analyses were performed to examine
dose–effect associations between neuropsychological/neuro-
physiological test scores or self-reported adverse health
symptoms obtained in the clinical interview and MnB or CEI.
For spirometry, the ratio percentage changes from T1 to T3 were
modelled using smoking and total years of welding before the
Bay Bridge as covariates and MnB or CEI as independent
variables.
To avoid bias of confounders in the dose–effect analyses,
potential confounding factors (age, years of education, ethni-
city and total years of welding before the Bay Bridge) were
included as covariates in multiple regressions for the
neuropsychological tests when test scores were not previously
adjusted for demographic variables in the test publisher norms.
Similarly, age, years of education and total years of welding
before the Bay Bridge were controlled in multiple logistic
regressions examining the association between exposure vari-
ables and adverse health symptoms. As smoking among
10 welders ceased at a minimum of >8 years before the study
date, the number of cigarettes smoked currently was included
as a possible confounder in the dose–effect analyses for
spirometry and olfactory tests. Smoking was not adjusted in
other dose–effect analyses as it was found to have neither
significant association with neuropsychological test perfor-
mance or self-reported symptoms, nor significant covariate




Table 1 shows the Bay Bridge welder group characteristics of
demographics, work and exposure, and biomarkers of trace
metals. On average, the welders were 43.8 years old, had
12.6 years of education, had welded already for 14.2 years
before the Bay Bridge, and did 16.5 months of confined space
welding at the Bay Bridge, where 22 of 43 welders were still
active at the end of January 2005. About half of the welder
group was composed of whites. As to smoking habits,
25 welders had never smoked and 10 were ex-smokers who
reported cessation of smoking at least 8 years before the actual
study date.
Exposure
Before April 2004, the welders reported wearing respirators on
average 6% of the time, whereas after this date they wore them
82% of the time. On-site Cal-OSHA inspections of the confined
spaces in which the welders worked noted deficiencies in
orientation and functioning of the ventilation devices and
identified overexposure to Mn in welding fumes.
Cal-OSHA data for May and June 2003 at the Bay Bridge
reconstruction site and personal exposure monitoring done by
the contracted laboratory during 75–80% of the work shifts
showed air levels of Mn ranging from 0.11 to 0.46 mg/m3.
Table 1 shows the Mn concentration in air, CEI and trace metal
concentrations in whole blood (Mn, Pb), serum/plasma (Mn,
Fe, Cu) and urine (Mn).
It is interesting to note that 55% of the average Mn-air levels
exceeded the Cal-OSHA PEL or ACGIH TLV, which is 0.2 mg/m3
for 8-h time weighted average (total dust). All biomarkers of
trace metals are considered normal, except MnB, the level of
which exceeded 10 mg/l in 16 of 37 (43%) welders. Moreover,
welders still actively welding at the time of the study (n = 21)
had a significantly higher mean (SD) MnB than those who had
stopped working at the Bridge 1 month or more ago (n = 16)—
that is, 10.3 (2.82) v 8.7 (1.74) mg/l (t35 = 2.00, p = 0.05).
Spirometry
Spirometric findings indicated that the welders’ lung function
decreased from time 1 to time 3 by 7% for FEV1, by 2% for FVC
and by 21.2% for the FEV1:FVC ratio. By the time of the study
(time 3), 33.3% of the welders had an abnormal FEV1:FVC
ratio. This was supported by the result of a paired t test analysis
of FEV1:FVC ratio in non-smokers for times 1 and 3 (t24 = 2.36,
p,0.05). The ratio percentage changes from time 1 to time 3
were regressed with smoking, total years of welding before the
Bay Bridge and each exposure variable (MnB or CEI), but no
significant dose–effect association was obtained.
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Neuropsychological testing
Table 2 shows the neuropsychological test results for selected
parameters which are frequently affected in parkinsonism,
including subtests of the WAIS-III (Letter–Number
Sequencing, Working Memory), the WMS-III, the Rey–
Osterrieth Complex Figure test, Design Fluency and Free
Sorting, Auditory Consonant Trigrams, Stroop, Trailmaking
Tests A and B, Grooved Pegboard, Fingertapping,
Dynamometer, Santa Ana Pegboard and Parallel Lines Test.
Bolded scores indicate the prevalence of welders with impaired
performance at least twice as large as expected. DSM-IV clinical
diagnoses in the workers’ compensation evaluation resulted in
classifying 79% with cognitive disorders.
Neurological and sensory examination
UPDRS results indicate that participants had total mean scores
of 6.79 (SD 5.08, range 0–19) on the activities of daily living
scale and 6.62 (SD 8.16, range 0–24) for the motor scale.
In addition, a bradykinesia score was computed by summing
scores of fingertaps, hand movements, rapid alternating move-
ments of hands, leg agility, arising from a chair, gait and body
bradykinesia/hypokinesia (mean (SD) 4.15 (6.53), range 0–20).
Results from the CATSYS Tests showed impairment of hand
tremor intensity (Harmonic Index) for 38.5–61.5% and postural
sway intensity for 51.4% in the fourth condition (on foam and
blinded; table 2).
Olfactory tests were compared with matched controls (by
age, years of education and smoking habits) of a control subject
database from the University of Pennsylvania Smell and Taste
Center, and showed that 88% of the welders scored below their
individually matched controls.33 The mean for welders was
significantly lower than that for their matched controls (F1,42
23.06, p,0.001).
Mood
Analyses of affect and mood indicated that the levels of clinical
depression and anxiety were .2 SDs above the normative
mean, indicating high levels of mood disturbance. Figure 2
shows the mean scores and standard errors of the welders’ SCL-
90-R, which indicate dysphoric mood and affect, signs of
withdrawal from life interests, lack of motivation and loss of
vital energy in addition to having clinical signs such as
nervousness, tension and trembling, with possible panic
episodes and feelings of terror. Psychoticism scores also were
moderately raised, supporting some of the welders’ statements
of having hallucinations while welding. The mean (SD) score of
the Beck Depression Inventories was 18.9 (10), and 63% of the
welders had clinical elevations. The Beck Anxiety Inventories
mean score was 22.6 (SD 14.6), with 80.5% clinical elevations.
DSM-IV diagnoses indicate 70% anxiety disorders and
61% depression for the welders.
Based on the Behavioural Risk Factor Surveillance System,
the average numbers of days reported for poor physical and
mental health were 14 and 15 of 30 days, respectively,
indicating significantly more poor health days than those
reported by the US Center for Disease Control.
Dose–effect relationships
Significant dose–effect relationships between neuropsychologi-
cal variables and blood Mn or CEI, shown in table 3, resulted
Table 1 Demographics, work and exposure characteristics, and biomarkers for trace
elements in Bay Bridge welders
Bay Bridge welders (n = 43)
n Mean (%) SD Range
Demographics
Age (years) 43 43.8 10 23–66





Current smokers 8 18.6
Ex-smokers 10 23.3
Work and exposure
Years of welding before Bay Bridge 43 14.2 11 0–39
Months of welding at Bay Bridge 43 16.5 6 6–28
Active welders at Bay Bridge*
Yes 22 51.2
No 21 48.8
Type of welding (% of time)
FCAW 40 66.5 28.5 0–100
SMAW 40 28.9 25 0–100
Respirator worn at Bay Bridge (% of time)
Before April 2004 42 6 19.7 0–100
After April 2004 29 82.2 28.5 0–100
Mn-air average (mg/m3) 40 0.21 0.08 0.01–0.38
Mn-air CEI (mg/m36month) 40 2.56 1.2 0.07–4.72
Biomarkers for trace metals
Mn-blood (mg/l) 37 9.6 2.5 5.13–15.3
Mn-urine (mg/g creatinine)` 36 0.28 0.460 0.00–1.93
Mn-plasma (mg/l) 33 0.58 0.13 0.22–0.85
Pb-blood (mg/dl) 37 2.8 1.1 1.24–6.59
Fe-plasma (mg/l)1 33 1127 327 469–2016
Cu-plasma (mg/l)1 33 807 120 601–1114
FCAW, flux cored arc welding; SMAW, shielded metal arc welding.
*Regarded as active welder if the welder left Bay Bridge ,1 month before the January 2005 assessment date.
Cut-off value upper normal: MnB, 10 mg/l; MnU, 2 mg/g creatinine; Mn-plasma, unknown; PbB, 25 mg/dl.
`LOD computed as 0.00003 mg/g creatinine.
1Normal range: Fe, 650–1700 mg/l; Cu, 700–1400 mg/l .37
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from multiple regression analyses with the covariates of years
of welding before Bay Bridge and age, years of education and
ethnicity when these covariates were not adjusted in their
respective norms. For blood Mn, significant associations were
obtained for Full Scale IQ; cognitive flexibility and executive
function; working memory, attention and concentration/learning;
and memory. For CEI, significant associations were obtained for
verbal IQ , working memory and concentration/learning, memory
and verbal skills. The partialled out effects of the potential
covariates show that the welding fume exposure on the Bay
Bridge remained significantly associated with impaired scores on
tests. All coefficients (b values) had negative signs, indicating a
Table 2 Neuropsychological tests by domain of function





Full IQ 35 95.26 12.93 20
Performance IQ 41 94.49 13.67 17.1
Verbal IQ 35 93.69 14.17 22.9
Cognitive flexibility and executive functioning
Stroop colour/word T score 42 39.76 13.40 45.2
Rey-Osterreith copy 43 30.60 3.73 69.8
Design fluency—total correct 41 10.24 2.84 9.8
Design fluency—percent design accuracy 41 8.73 2.69 24.4
Design fluency—switching 41 10.61 2.64 4.9
Sorting—Recognition Description score 37 7.65 2.78 43.2
Sorting—recognition v free sorting 37 7.30 3.15 35.1
Information processing speed
Stroop colour T score 42 38.98 10.59 45.2
Stroop word T score 42 39.10 11.80 40.5
Working memory/attention and concentration/learning
WAIS-III WMI 40 90.6 13.24 25
Digit span 41 8.44 2.37 26.8
Digit span—longest digits (forward) 41 6.1 1.43 17.5
Digit span—longest digits (backward) 41 4.22 1.01 27.5
Letter–number sequencing 40 8.38 3.04 32.5
WMS-III Auditory Immediate Memory Index 37 90.32 13.59 32.4
Logical memory I 37 7.97 3.14 43.2
Verbal paired associates I 37 8.65 2.19 18.9
Word lists 1 recall 36 7.78 3.34 44.4
Auditory consonant trigrams 30 43 10.16 3.27 51.2
Auditory consonant trigrams 90 43 7.86 3.25 55.8
Auditory consonant trigrams 180 43 6.28 3.31 48.8
Rey–Osterreith immediate recall 43 38.79 13 46.5
Memory
WMS-III Auditory Delayed Index 36 94.03 12.61 13.9
Verbal paired associates II 37 8.86 2.52 18.9
Word lists 2 recall 35 9.57 3.38 22.9
Rey–Osterreith delayed recall 43 39.02 13.18 60.5
Visuomotor tracking speed
WAIS-III PSI 42 89.52 11.99 33.3
Digit symbol coding 42 7.79 2.37 31
Trail Making Test A T score 42 44.43 11.78 31
Verbal skills
WAIS-III VCI 35 95.11 15.53 17.1
WRAT3-reading 34 93.65 13.91 23.5
Comprehension 41 8.78 2.92 24.4
Similarities 35 8.71 3.56 28.6
Vocabulary 37 8.62 3.12 35.1
Information 35 9.94 2.71 17.1
Motor dexterity and strength
Grooved pegboard T score (dominant hand) 43 53.93 12.27 14
Finger tapping Tscore (dominant hand) 43 46.42 13.76 23.3
Dynamometer T-score (dominant hand) 42 35.33 8.36 52.4
Santa Ana pegboard (dominant hand) 43 21.89 3.83 97.7
Tremor/postural sway
Parallel Line Test 43 2.12 1.22 90.7
CATSYS Tremor: Harmonic Index (right) 39 0.15 0.11 38.5
CATSYS tremor: Harmonic Index (left) 39 2.32 0.56 61.5
CATSYS sway 4: sway intensity 35 8.84 5.11 51.4
CATSYS, computer assisted tremor analysis system; VCI, Verbal Comprehension Index; WAIS-III, Wechsler Adult
Intelligence Scale; WRAT, Wide Range Achievement Test 3; WMS III, Wechsler Memory Scale.
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consistent direction of effect—that is, the higher the Mn values,
the less favourable the neuropsychological outcomes. A substan-
tial amount of variance was uniquely accounted for by MnB
shown in table 3 and CEI as shown in table 4 (expressed by sr2).
Partial regression plots (fig 3) illustrate the inverse slopes for the
regression lines of the residuals for the age-adjusted neuropsy-
chological tests with MnB—that is, Full Scale IQ , Word List recall
total (WMS-III), Letter–number sequencing (WAIS-III) and
Design Fluency total correct—and with CEI—that is, Verbal IQ,
Verbal Comprehension Index (WAIS-III) Working Memory Index
(WAIS-III), and Auditory Immediate Memory Index (WMS-III).
Multiple regressions indicate that an MnB increment of 5.0 mg/l
results in a decrease in Full Scale IQ of 10 points (B = 22.0,
SE = 1), and a CEI increment of 2.4 mg/m36month in a decrease
of 12 points in verbal IQ (B = 25.2, SE = 1.7) and in a loss of 9
points for Working Memory Index (B = 23.8, SE = 1.8).
Logistic regression analyses for symptoms while working
were performed to examine their relationship with MnB or CEI,
by controlling possible confounders such as age, years of
education and years of welding before the Bay Bridge. A unit
increase in MnB showed a significant association with
depression (OR = 1.5, p,0.05, 95% CI 1.0to 2.2). There were
also significant associations between the CEI and sexual
dysfunction (OR = 2.6, p,0.05, 95% CI 1.2 to 5.5), headache
(OR = 2.0, p,0.05, 95% CI 1 to 4), depression (OR = 2.8,
p,0.01, 95% CI 1.3 to 6) and fatigue (OR = 2.7, p,0.05, 95% CI
1.3 to 5.9). No significant association was obtained for
hallucination, sleep disturbance, tremors, anxiety and numb-
ness. Bonferroni adjustments were not made as each symptom
is considered its own domain.
DISCUSSION
Although there is a large body of literature on the associa-
tion between occupational Mn exposure and ill health, a
controversy remains whether Mn exposure in welders produces
welding-related symptoms and associated specific deficits in
Figure 2 T scores of the Symptom Checklist 90-R (SCL-90-R), mean (SEM), for the nine clinical and three summary scales.
Table 3 Multiple regression analyses on neuropsychological test scores and using Mn in blood as a predictor
Mn in blood (mg/l)
b sr2 (95% CI of sr2) p Value
sr2 Control variables
Age Edu Eth Yr W
IQ
Full IQ 20.34 0.09 (0–0.28) 0.053 – 0.10 0.05 0.01
Verbal IQ 20.31 0.08 (0–0.25) 0.061 – 0.18 0.06 0
Cognitive flexibility and executive functioning
Design fluency—total correct 20.51 0.22 (0–0.44) 0.004 – 0.02 0.04 0.01
Design fluency—percentage design accuracy 20.43 0.15 (0–0.36) 0.012 – 0.05 0.01 0.04
Design fluency—switching 20.39 0.13 (0–0.32) 0.027 – 0.01 0.09 0.01
Working memory/attention and concentration/learning
WAIS-III WMI 20.29 0.07 (0–0.23) 0.095 – 0.11 0.14 0
Letter–number sequencing 20.38 0.12 (0–0.32) 0.035 – 0.09 0.00 0.01
Word lists 1 recall 20.29 0.07 (0–0.23) 0.042 – 0.41 0.01 0.01
Memory
WMS-III WMI 20.36 0.11 (0–0.3) 0.061 – 0.02 0 0.02
WMS-III Auditory Delayed Index 20.3 0.08 (0–0.25) 0.093 – 0.07 0.04 0.09
Verbal Paired Aassociates II 20.40 0.14 (0–0.35) 0.041 – 0.01 0.01 0.01
Verbal skills
WAIS-III VCI 20.27 0.06 (0–0.21) 0.094 – 0.18 0.08 0
Edu, education; Eth, ethnicity; sr2, squared semi-partial correlation; VCI, Verbal Comprehension Index WAIS-III, Wechsler Adult Intelligence Scale; WMS III, Wechsler
Memory Scale; Yr W, years of prior welding.
–demographic variable (age) was not entered in multiple regressions.
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neuropsychological and neurological function. Many of the
previous welder studies did not report/measure air Mn, did not
have the type of extensive exposure (air Mn) and biomarker
measurements (blood, plasma and urine), or lacked the
multidisciplinary methods (neurological, neuropsychological
and respiratory assessment) used in the present study. There
are as yet no reports of groups of confined space welders
working in poor ventilation conditions without adequate
personal protection equipment who underwent full clinical
neuropsychological and neurological examinations. The Bay
Bridge welders afforded a unique opportunity to study health
effects in the context of a ‘‘natural experiment’’ for this type of
welding fume exposures. Although respiratory protection
should have been required according to Cal-OSHA regulations
and NIOSH guidelines, this was not done.24 This group
of middle age welders, who were pre-screened during a
Table 4 Multiple regression analyses on neuropsychological test scores using Mn in Cumulative Exposure Index (CEI) as a
predictor
CEI (mg Mn/m3 6month)
b sr2 (95% CI of sr2) p Value
sr2 control variables
Age Edu Eth Yr W
IQ
Verbal IQ 20.44 0.16 (0–0.37) 0.004 – 0.16 0.03 0
Cognitive flexibility and executive functioning
Stroop colour-word T score 20.30 0.07 (0–0.22) 0.097 – 0.04 0.01 0.01
Working memory/attention and concentration/learning
WAIS-III WMI 20.35 0.1 (0–0.26) 0.041 – 0.08 0.02 0.01
Digit span (forward) 20.30 0.07 (0–0.21) 0.081 – 0.06 0.06 0.02
Letter–number sequencing 20.39 0.12 (0–0.3) 0.036 – 0.05 0 0.02
WMS-III Auditory Immediate Memory Index 20.42 0.14 (0–0.34) 0.017 – 0.03 0.05 0.06
Verbal Paired Associates I 20.5 0.2 (0–0.42) 0.007 – 0.01 0.01 0.08
Auditory consonant trigrams total score 20.34 0.09 (0–0.24) 0.071 0.05 0.02 0 0.05
Memory
WMS-III WMI 20.38 0.11 (0–0.29) 0.052 – 0 0 0.01
Logical memory I 20.31 0.08 (0–0.24) 0.09 – 0.03 0.08 0.03
Verbal skills
WAIS-III VCI 20.35 0.1 (0–0.28) 0.026 – 0.19 0.05 0
Comprehension 20.51 0.2 (0–0.41) 0.003 – 0.06 0 0
Similarities 20.34 0.09 (0–0.27) 0.053 – 0.09 0.06 0
Vocabulary 20.43 0.15 (0–0.35) 0.006 – 0.13 0.03 0
CEI, Cumulative Exposure Index; sr2, squared semi-partial correlation; WAIS-III, Wechsler Adult Intelligence Scale; WMS III, Wechsler Memory Scale; VCI, Verbal
Comprehension Index.
–demographic variable (age) was not entered in multiple regressions.
Figure 3 Graphic representation of partial regression graphs for selected tests and manganese in blood (MnB) and Cumulative Exposure Index (CEI).
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competitive hiring process to assure good health and fitness,
were highly skilled, competent and physically fit at the
beginning of their employment on the bridge.
A major asset of the study is that the neurological effects
identified in the Bay Bridge welders were detected by a
neurologist using UPDRS examination, a reliable clinical tool
widely used for assessing parkinsonian syndromes. Abnormal
mean scores for UPDRS and bradykinesia were found in the
welder group. Another important result is the detection of
increased hand tremor and body sway with the CATSYS
instrument, which allows objective measurements based on
physics. Tremor, a hallmark of parkinsonism, was found to be
present 39–90% of the time on three different methods of
tremor testing. Motor dexterity and speed also was impaired
52–95% of the time on various neuropsychological measures.
Welders, by the nature of their job, are required to have good
speed and efficient motor performance, and are expected to
have scored above average before their confined space welding
period. The present results may underestimate the true effects
size—this could be answered in a longitudinal study beginning
with apprentice welders.
The study also showed strong suggestive evidence that as the
welders continued to be exposed to Mn in welding fumes on
the bridge, their intelligence level may have declined by as
much as 10–12 IQ points, although some uncertainty cannot be
ruled out because of the small sample size, lack of baseline and
longitudinal data. Although lead has been acknowledged as a
neurotoxicant lowering IQ in children, this is the first report of
adults having IQ decrements associated with occupational Mn
exposure. Recently, Wright et al38 reported findings of an
association between Mn in hair and lowered IQ in 32 children
from Ottawa County in northeastern Oklahoma who lived at
the Tar Creek Superfund clean-up site, slated for clean-up by
the US Environmental Protection Agency. Wasserman et al39
reported that exposures to Mn in tube-well water in Araihazar,
Bangladesh, produced similar decrements as those reported
here in welders—that is, Mn exposure correlated with Full
Scale IQ, performance and verbal IQ raw scores. This scientific
convergence of findings suggests a detrimental effect of Mn on
cognitive function resembling the negative effects of lead in
children (blood lead levels were negligible in the welders)—
regardless of the route of exposure (inhalation or oral). The
finding of a dose–effect association between increased internal
Mn exposure (moderate elevations of MnB) and lower IQ in a
group of welders is of concern and should be followed up with
larger observational studies of welding in confined spaces and
other occupational settings with Mn exposure. Although the
level of impairment for the neuropsychological test results is
relatively small compared with more extreme findings of long-
term welders reported previously,6 14 the inverse dose–effect
relationships between Mn exposure and IQ or other cognitive
functions obtained in the present study suggest an increased
population-attributable risk and represent a change, albeit
small, in the distribution of IQ scores above some threshold of
Mn exposure.
Overall, the skilled welder group, when interviewed by the
clinical neuropsychologists, reported good mental health before
welding on the bridge. After employment at the bridge, 63%
and 81% scored clinically depressed and anxious, respectively.
Mood effects have been described in many studies of Mn
exposure.4 6 14 40 Sleep and sexual disturbance, such as loss of
libido and decreased potency, were reported by all but one
welder. About 70% of welders who had workers’ compensation
evaluation were referred for clinical psychotherapeutic inter-
ventions.
Good or adequate olfactory ability contributes significantly to
the enjoyment of life, and olfactory changes serve as an early
warning system for the detection of overexposure to chemicals,
fire, gas, spoiled foods or dangerous levels of air contamina-
tion.33 Olfactory loss has been associated with Parkinson’s
disease and head trauma,41 but inhalation exposure to
manganese fume/dust may also entail olfactory changes as
reported in a study of Mn-exposed ferromanganese-alloy
workers.42 Recent studies in rats strongly suggest olfactory
nerve transport as a significant route for central nervous system
uptake of manganese from inhaled fine43 (mass median
aerodynamic diameter 1.3 mm) or ultrafine44 (count median
diameter 0.031 mm) Mn-oxide aerosols. Inhalation exposure of
fine (6 h/day, 15 days; 3 mg/m3) and ultrafine (6 h/day,
12 days; 0.5 mg/m3) particles resulted in, respectively, 1.7 and
3.5 higher Mn concentrations in olfactory bulbs of exposed rats
compared with controls. For ultrafine Mn-oxide aerosol
exposure, an increased gene expression was found for tumour
necrosis factor a in the olfactory bulb, frontal cortex, midbrain
and striatum. For the olfactory bulb, at least a twofold increase
over controls was shown for expression of other genes involved
in stress response and inflammation.44 Elder et al44 stated that,
as the olfactory neuronal translocation pathway was also
shown in non-human primates, it is likely to be operative in
humans as well. These experimental findings offer a strong
basis for a causal association between the Bay Bridge welders’
changes in smell identification and inhalation exposure to Mn
from confined space welding generating fine/ultrafine particle
aerosols. With more than three quarters of the welders showing
impaired sense of smell, this loss leaves them deprived of
olfaction as a sensory warning sign making them potentially
more vulnerable to future injuries.
Most of the welders reported having developed respiratory
symptoms (93%). The evolution of pulmonary abnormalities
suggests that the longer they welded in the confined spaces on
the Bay Bridge, the more the air flow obstruction developed.
One third of the welder group presented with a mild obstructive
syndrome at an average of 20.9 months after they began
working on the bridge. They were referred for further
pulmonary follow-up. The spirometric results suggest that
further testing is indicated, such as inhaled bronchial challenge
or clinical exercise testing. Those welders who continue to
exhibit welding-related respiratory symptoms should also be
considered candidates for additional pulmonary testing.36
Both the raised MnB levels and the increase in Mn levels in
the air of the Bay Bridge welders’ working environment suggest
that the measurable exposure to Mn is the likely cause of their
ill physical and mental health. However, MnB analyses are
useful only if they are done within ,1 month of cessation of
welding. A follow-up is needed to determine if the welders’
condition has improved since leaving this work site. The
confined space welding and simultaneous unprotected Mn
exposure on the bridge were relatively brief (on average
16.5 months), which may make reversibility of their symptoms
and deficits possible.
Both neurological and neuropsychological methods were
found to be complementary in the diagnosis of welding-
associated parkinsonism and, moreover, neuropsychological
testing is shown to contribute significantly to the clinical
neurological and pulmonary definition of a comprehensive
portrait for health effects in Mn-exposed welders. A more
complete portrait includes also tremor, IQ and other cognitive
deficits, mood disturbance, sleep and sexual perturbations,
changes in smell, and surprisingly early lung function effects as
well, most probably linked to the size of welding fume
particulate being predominantly in the respirable range.
A limitation of this study is the lack of a matched control
group for comparison. However, as can be seen in the
welders’ demographic characteristics, they are similar to the
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standardisation samples of the neuropsychological tests used.
This similarity suggests that comparisons with the standardised
age norms of the tests used are likely appropriate. Although the
welders were not drawn at random, a selection bias is not likely
because, according to several foremen, most (90%) of the
welders worrying about health effects from welding fume
exposure on the Bay Bridge have been included in our sample
and are thus likely representative of the overall group.
Significant dose–effect associations in this relatively small
group support and strengthen the finding of multiple adverse
health effects in these welders, despite the conservative
approach used by taking into account up to four possible
covariates in the multiple regression models. Although this may
have had some influence in obtaining statistical significance,
the remaining ‘‘explained’’ variance after adjustment for the
covariates still supports inverse associations between MnB or
CEI and several test performances. As the sample size was not
under the investigator’s control, replication using a larger
sample of welders would be desirable to confirm these findings.
It is highly recommended for occupational physicians and
other health professionals, who may evaluate or treat a welder,
to consider exposure to Mn fumes as a possible cause of their ill
health. The evaluating physician should refer such welders to
neuropsychologists and neurologists for further assessments,
which will assist in diagnostic considerations. Clearly, the loss
of almost 1 SD of IQ, if this loss persists, will affect the welders’
lives permanently, lowering their potential to earn a good living
and their learning of new information which is required for
work and for independent living skills. It is a high cost to
society, as aptly stated by Weiss 45: ‘‘That cost is the decline in
functional capacity. If the disease is a gradually progressive one,
the ability of its victims to function effectively and efficiently
will be impaired at stages of the disease far earlier than its
eventual detection.’’ Given these findings, enforcing protection
by agencies such as NIOSH and Cal-OSHA is essential, and
ongoing inspections to ascertain compliance can yield signifi-
cant benefit to welders and to the society.
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